Evidence map›Paper›PMID 21633093›Full record

ArticleJournal of lipid research2011

A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA.

Sophie C Cazanave, Justin L Mott, Nafisa A Elmi, Steven F Bronk, Howard C Masuoka, Michael R Charlton, Gregory J Gores

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 104 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease.International journal of biological sciences · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Apoptosis and non-alcoholic fatty liver diseases.World journal of gastroenterology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sophie C CazanaveDivision of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic, Rochester, MN, USA.
Justin L Mott
Nafisa A Elmi
Steven F Bronk
Howard C Masuoka
Michael R Charlton
Gregory J Gores
Mayo Clinic · USMayo Clinic in Arizona · US

Funding

PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2M
MECHANISMS OF LIVER CELL INJURYR01DK041876 · NIDDK · MAYO CLINIC ROCHESTER · PI GORES, GREGORY J. · 1992 to 2019
$3.6M
MECHANISMS OF LIVER CELL INJURYR37DK041876 · NIDDK · MAYO CLINIC ROCHESTER · PI GORES, GREGORY J. · 2000 to 2009
$2.9M
Pathophysiology and Characterisation of NAFLDR01DK069757 · NIDDK · MAYO CLINIC ROCHESTER · PI CHARLTON, MICHAEL R · 2005 to 2009
$1.5M
Cholangiocyte microRNAs Regulate Mcl-1 and Cell DeathK01DK079875 · NIDDK · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI MOTT, JUSTIN L. · 2007 to 2011
$731k
INTRACELLULAR PH IN LIVER CELL INJURYR29DK041876 · NIDDK · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI GORES, GREGORY J. · 1989 to 1992
–
NIDDK NIH HHS 5R01 DK-069757-05NIDDK NIH HHS DK-41876NIDDK NIH HHS K01 DK-079875NIDDK NIH HHS K01 DK079875NIDDK NIH HHS P30 DK-084567NIDDK NIH HHS P30 DK084567NIDDK NIH HHS R01 DK041876NIDDK NIH HHS R01 DK069757NIDDK NIH HHS R37 DK041876
6 · The paper itself

Abstract

Saturated free fatty acids (FFA) induce hepatocyte lipoapoptosis, a key mediator of liver injury in nonalcoholic fatty liver disease (NAFLD). Lipoapoptosis involves the upregulation of the BH3-only protein PUMA, a potent pro-apoptotic protein. Given that dysregulation of hepatic microRNA expression has been observed in NAFLD, we examined the role of miRNA in regulating PUMA expression during lipotoxicity. By in silico analysis, we identified two putative binding sites for miR-296-5p within the 3' untranslated region (UTR) of PUMA mRNA. Enforced miR-296-5p levels efficiently reduced PUMA protein expression in Huh-7 cells, while antagonism of miR-296-5p function increased PUMA cellular levels. Reporter gene assays identified PUMA 3'UTR as a direct target of miR-296-5p. The saturated FFA, palmitate, repressed miR-296-5p expression; and Huh-7 cells were sensitized to palmitate-induced lipotoxicity by antagonism of miR-296-5p function using a targeted locked nucleic acid (LNA). Finally, miR-296-5p was reduced in liver samples from nonalcoholic steatohepatitis (NASH) patients compared with patients with simple steatosis (SS) or controls. Also miR-296-5p levels inversely varied with PUMA mRNA levels in human liver specimens. Our results implicate miR-296-5p in the regulation of PUMA expression during hepatic lipoapoptosis. We speculate that enhancement of miR-296-5p expression may represent a novel approach to minimize apoptotic damage in human fatty liver diseases.

Indexed as

Apoptosis Regulatory ProteinsMicroRNAsProto-Oncogene Proteins3' Untranslated RegionsAgedAnimalsApoptosisBinding SitesCell Line, TumorFatty LiverGene ExpressionGenes, ReporterHepatocytesHumansLiverLuciferases3' Untranslated RegionsApoptosis Regulatory ProteinsBBC3 protein, humanLuciferasesMicroRNAsPalmitatesProto-Oncogene Proteins

Identifiers

PMID21633093
PMCPMC3137017
OpenAlexW2104745602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.